查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479105

纸本诊断市场：现况分析与预测（2023-2030）

Paper Diagnostics Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计 2023 年至 2030 年，纸本诊断市场的复合年增长率约为 8.2%。纸本诊断通常透过印刷、点样和固定等各种技术将抗体、核酸和酵素等生物分子识别元件整合到纸质基材中。纸张可作为固体支撑基质，用于进行生化反应并捕获生物样本（例如血液、尿液、唾液和环境样本）中存在的目标分析物。心臟病、心臟衰竭、心肌梗塞、肝臟疾病和其他慢性疾病等心血管疾病的流行是纸本诊断市场的关键驱动因素。由于这些疾病持续影响全球很大一部分人口，因此对这些疾病的诊断和监测的需求仍然很高。例如，到2024年，全球约有6.2亿人将患有心臟和循环系统疾病。据估计，全世界每 13 人就有 1 人患有心臟病或循环系统疾病。此外，技术进步也促使了更灵敏、更特异的纸本诊断试剂盒的开发。

根据试剂盒类型，市场分为侧流检测、试纸和纸基微流体。预计量油尺类别在预测期内将占据最高占有率。量油尺因其简单性、多功能性和适用于现场检测应用而在纸本诊断市场中不断增长。基于试纸的测试通常涉及将纸条（试纸）浸入含有目标分析物的样本中，其中发生特定的生化反应，产生可见的颜色变化，表明分析物的存在或浓度。例如，2021 年，几家公司正在开发基于试纸的抗原测试，以快速检测导致 COVID-19 的 SARS-CoV-2 病毒。这些测试为大流行期间的大规模筛检和监测活动提供了方便且经济高效的解决方案。

根据设备类型，纸本诊断市场分为诊断设备、监测设备。其中，由于多种因素推动了对创新和可靠诊断技术的需求，诊断设备领域的纸本诊断市场正在成长。诊断设备包括用于执行诊断测试、分析样本和解释结果的各种仪器、平台和系统。这些设备能够准确、及时地诊断各种医疗状况，在医疗保健服务中发挥重要作用。此外，人们越来越认识到预防性保健和早期发现疾病的重要性，因此重视筛检计划和定期健康检查。

依应用划分，市场分为临床诊断、食品品质检测和环境监测。预计临床诊断类别在预测期内将表现出最高的复合年增长率。在纸本诊断市场中，临床诊断是指应用纸本诊断测试和设备来诊断、监测和管理临床环境中的各种状况和疾病。临床诊断包括广泛的应用，包括传染病检测、慢性病管理、癌症筛检以及生物标记和生理参数的监测。

依最终用户划分，纸本诊断市场分为家庭医疗保健、辅助生活医疗保健设施、医院/诊所等。其中，医院/诊所类别预计在预测期内纸本诊断的采用率将会增加。由于多种因素推动了医疗环境中对快速、经济高效且易于使用的诊断解决方案的需求，纸本诊断市场的最终用户医院和诊所部分正在成长。医院和诊所是寻求诊断、治疗和管理各种医疗状况的患者的初级保健中心。此外，对快速诊断、治疗监测和患者管理的需求正在推动医院和诊所对即时检测的需求。纸本诊断测试具有快速週转时间、易于使用和便携等优点，使其适合医疗保健环境中的现场护理测试应用。

为了更瞭解纸本诊断产业的市场实施情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太其他地区）和世界其他地区。北美纸本诊断市场的推动因素包括心血管疾病、肝损伤和糖尿病等慢性病的盛行率不断上升、医疗保健专业人员和公众对纸本诊断的认识不断提高、先进技术的发展以及治疗范围的扩大预计市场将因这一增长而继续增长。例如，根据 CDC 的数据，2019 年，美国每年约有 805,000 人心臟病发作。大约五分之一的心臟病发作者没有任何症状，这意味着伤害已经造成，但患者并没有意识到。

市场主要参与者包括Bio-Rad Laboratories, Inc.、BIOMERIEUX.、Abbott、Siemens Healthcare Private Limited、Micro Essential Laboratory Inc、Abingdon Health、AnteoTech、Bioneer Corporation、EKF Diagnostics Holdings plc、Acon Laboratories, Inc.等。

目录

第一章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第二章 研究方法或前提条件

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19对纸本诊断市场的影响

第六章 2020-2030年全球纸本诊断市场收入

第七章依套件类型划分的市场分析

  • 侧流分析
  • 量油尺
  • 纸基微流体

第 8 章依设备类型划分的市场分析

  • 诊断设备
  • 监控装置

第九章应用市场分析

  • 临床诊断
  • 食品品质检验
  • 环境监测

第10章最终用户的市场分析

  • 家庭保健
  • 辅助生活医疗设施
  • 医院和诊所
  • 其他

第十一章区域市场分析

  • 北美纸本诊断市场
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲纸本诊断市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区纸质诊断市场
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 其他地区纸本诊断市场

第十二章 纸本诊断市场动态

  • 市场驱动力
  • 市场课题
  • 影响分析

第十三章 论文诊断市场机会

第14章论文诊断市场趋势与见解

第十五章供需分析

  • 需求面分析
  • 供给侧分析

第十六章价值链分析

第17章价格分析

第18章 竞争场景

  • 竞争格局
    • 波特五力分析

第十九章 公司简介

  • Bio-Rad Laboratories, Inc.
  • BIOMERIEUX.
  • Abbott
  • Siemens Healthcare Private Limited
  • Micro Essential Laboratory Inc
  • Abingdon Health
  • AnteoTech
  • Bioneer Corporation
  • EKF Diagnostics Holdings plc
  • Acon Laboratories, Inc

第二十章 免责声明

简介目录
Product Code: UMHE212714

The Paper Diagnostics market is expected to register a CAGR of approx. 8.2% over the period of 2023-2030. Paper diagnostics typically involve the integration of biomolecular recognition elements, such as antibodies, nucleic acids, or enzymes, onto paper substrates through various techniques, such as printing, spotting, or immobilization. The paper serves as a solid support matrix for conducting biochemical reactions and capturing target analytes present in biological samples, such as blood, urine, saliva, or environmental samples. The prevalence of cardiovascular diseases, such as heart attacks, heart failure, and myocardial infarctions, liver disorder and other chronic diseases are significant drivers of the paper diagnostics market. As these conditions continue to affect a large portion of the population globally, the demand for diagnosing and monitoring these diseases remains high. For instance, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. Globally it is estimated that 1 in 13 people are living with a heart or circulatory disease. Furthermore, advances in technology have led to the development of more sensitive and specific paper diagnostics kits.

Based on Kit Type, the market is segmented into lateral flow assays, dipsticks, and paper-based microfluidics. The dipsticks category is expected to witness the highest share during the forecast period. Dipsticks are experiencing growth in the paper diagnostic market due to their simplicity, versatility, and suitability for point-of-care testing applications. Dipstick-based assays typically involve immersing a paper strip (the dipstick) into a sample containing the target analyte, where specific biochemical reactions occur and result in a visible color change, indicating the presence or concentration of the analyte. For instance, in 2021, several companies have developed dipstick-based antigen tests for rapid detection of SARS-CoV-2, the virus that causes COVID-19. These tests offer a convenient and cost-effective solution for mass screening and surveillance efforts during the pandemic.

Based on device type, the paper diagnostics market has been classified as diagnostic devices, monitoring devices. Among them, the diagnostic device segment is experiencing growth in the paper diagnostic market due to several factors driving demand for innovative and reliable diagnostic technologies. Diagnostic devices encompass a wide range of instruments, platforms, and systems used for performing diagnostic tests, analyzing samples, and interpreting results. These devices play a crucial role in healthcare delivery by enabling accurate and timely diagnosis of various medical conditions. Furthermore, growing awareness of preventive healthcare and the importance of early disease detection has led to an increased emphasis on screening programs and regular health checks.

Based on application, the market is segmented clinical diagnostics, food quality testing, and environmental monitoring. The clinical diagnostics category is expected to witness the highest CAGR during the forecast period. In the paper diagnostic market, clinical diagnostics refer to the application of paper-based diagnostic tests and devices for diagnosing, monitoring, and managing various medical conditions and diseases in clinical settings. Clinical diagnostics encompasses a wide range of applications, including infectious disease testing, chronic disease management, cancer screening, and monitoring of biomarkers or physiological parameters.

Based on the End-User, the Paper Diagnostics market has been classified into home healthcare, assisted living healthcare facilities, hospital and clinics, others. Among them, the hospital and clinics category is to witness higher adoption of Paper Diagnostics during the forecast period. The hospital and clinics segment in the end-user segment of the paper diagnostic market is experiencing growth due to several factors driving demand for rapid, cost-effective, and accessible diagnostic solutions in healthcare settings. Hospitals and clinics serve as primary points of care for patients seeking diagnosis, treatment, and management of various medical conditions. Furthermore, there is a growing demand for point-of-care testing in hospitals and clinics, driven by the need for rapid diagnosis, treatment monitoring, and patient management. Paper-based diagnostic tests offer advantages such as rapid turnaround time, ease of use, and portability, making them well-suited for POCT applications in healthcare settings.

For a better understanding of the market adoption of the Paper Diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America Paper Diagnostics market is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic diseases such as cardiovascular disease, liver disorder, diabetes and many more and growing awareness of paper diagnostics among healthcare professionals and the general population, development of advanced techniques and the rise in treatment option. For instance, in 2019, according to CDC, Every year, about 805,000 people in the United States have a heart attack. About 1 in 5 heart attacks are silent, the damage is done, but the person is not aware of it.

Some of the major players operating in the market include Bio-Rad Laboratories, Inc., BIOMERIEUX., Abbott, Siemens Healthcare Private Limited, Micro Essential Laboratory Inc, Abingdon Health, AnteoTech, Bioneer Corporation, EKF Diagnostics Holdings plc, Acon Laboratories, Inc

TABLE OF CONTENTS

1MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Paper Diagnostics Market
  • 2.2.Research Methodology of the Paper Diagnostics Market
  • 2.4.Respondent Profile

3MARKET SYNOPSIS

4EXECUTIVE SUMMARY

5IMPACT OF COVID-19 ON THE PAPER DIAGNOSTICS MARKET

6GLOBAL PAPER DIAGNOSTICS MARKET REVENUE, 2020-2030F

7MARKET INSIGHTS BY KIT TYPE

  • 7.1.Lateral Flow Assays
  • 7.2.Dipsticks
  • 7.3.Paper Based Microfluidics

8MARKET INSIGHTS BY DEVICE TYPE

  • 8.1.Diagnostic Devices
  • 8.2.Monitoring Devices

9MARKET INSIGHTS BY APPLICATION

  • 9.1.Clinical Diagnostics
  • 9.2.Food Quality Testing
  • 9.3.Environmental Monitoring

10MARKET INSIGHTS BY END-USERS

  • 10.1.Home Healthcare
  • 10.2.Assisted Living Healthcare Facilities
  • 10.3.Hospital and Clinics
  • 10.4.Others

11MARKET INSIGHTS BY REGION

  • 11.1NORTH AMERICA PAPER DIAGNOSTICS MARKET
    • 11.1.1.U.S.
    • 11.1.2.Canada
    • 11.1.3.Rest of North America
  • 11.2EUROPE PAPER DIAGNOSTICS MARKET
    • 11.2.1.Germany
    • 11.2.2.U.K.
    • 11.2.3.France
    • 11.2.4.Italy
    • 11.2.5.Spain
    • 11.2.6.Rest of Europe
  • 11.3ASIA PACIFIC PAPER DIAGNOSTICS MARKET
    • 11.3.1.China
    • 11.3.2.Japan
    • 11.3.3.India
    • 11.3.4.Rest of Asia-Pacific
  • 11.4REST OF THE WORLD PAPER DIAGNOSTICS MARKET

12PAPER DIAGNOSTICS MARKET DYNAMICS

  • 12.1.Market Drivers
  • 12.2.Market Challenges
  • 12.3.Impact Analysis

13PAPER DIAGNOSTICS MARKET OPPORTUNITIES

14PAPER DIAGNOSTICS MARKET TRENDS & INSIGHTS

15DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1.Demand Side Analysis
  • 15.2.Supply Side Analysis

16VALUE CHAIN ANALYSIS

17PRICING ANALYSIS

18COMPETITIVE SCENARIO

  • 18.1.Competitive Landscape
    • 18.1.1Porter's Five forces analysis

19COMPANY PROFILED

  • 19.1.Bio-Rad Laboratories, Inc.
  • 19.2.BIOMERIEUX.
  • 19.3.Abbott
  • 19.4.Siemens Healthcare Private Limited
  • 19.5.Micro Essential Laboratory Inc
  • 19.6.Abingdon Health
  • 19.7.AnteoTech
  • 19.8.Bioneer Corporation
  • 19.9.EKF Diagnostics Holdings plc
  • 19.10.Acon Laboratories, Inc

20DISCLAIMER